Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 632

1.

Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.

Pollack MH, Tiller J, Xie F, Trivedi MH.

J Clin Psychopharmacol. 2008 Jun;28(3):308-16. doi: 10.1097/JCP.0b013e318172b45f.

PMID:
18480688
2.

The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.

Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K.

J Clin Psychiatry. 2005 Nov;66(11):1401-8.

PMID:
16420077
4.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
5.

Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.

Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J; Deramciclane Dose-Finding Study Group..

Eur Neuropsychopharmacol. 2005 Dec;15(6):617-23.

PMID:
15949921
6.

An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder.

Schwartz TL, Nasra GS, Ashton AK, Kang D, Kumaresan H, Chilton M, Bertone F.

Ann Clin Psychiatry. 2007 Jan-Mar;19(1):25-30.

PMID:
17453658
7.

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.

Adams JB, Pyke RE, Costa J, Cutler NR, Schweizer E, Wilcox CS, Wisselink PG, Greiner M, Pierce MW, Pande AC.

J Clin Psychopharmacol. 1995 Dec;15(6):428-34.

PMID:
8748432
8.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
9.

The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.

Davidson JR, Brady K, Mellman TA, Stein MB, Pollack MH.

J Clin Psychopharmacol. 2007 Feb;27(1):85-8.

PMID:
17224720
10.

An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD)

Cutler NR, Sramek JJ, Macpherson AE, Doss MG, Benes CO, Howard SF.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jul;18(4):685-94.

PMID:
7938559
11.
12.

Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.

Llorca PM, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher JP, Sermet E, Servant D.

J Clin Psychiatry. 2002 Nov;63(11):1020-7.

PMID:
12444816
13.
14.

Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.

Fresquet A, Sust M, Lloret A, Murphy MF, Carter FJ, Campbell GM, Marion-Landais G.

Ann Pharmacother. 2000 Feb;34(2):147-53.

PMID:
10676820
15.

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.

Depress Anxiety. 2008;25(3):182-9.

PMID:
17311303
16.

Open-label tiagabine monotherapy for major depressive disorder with anxiety.

Carpenter LL, Schecter JM, Tyrka AR, Mello AF, Mello MF, Haggarty R, Price LH.

J Clin Psychiatry. 2006 Jan;67(1):66-71.

PMID:
16426090
18.

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.

Davidson JR, Bose A, Korotzer A, Zheng H.

Depress Anxiety. 2004;19(4):234-40.

PMID:
15274172
19.

Tiagabine in anxiety disorders.

Schwartz TL, Nihalani N.

Expert Opin Pharmacother. 2006 Oct;7(14):1977-87. Review.

PMID:
17020423
20.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005.

PMID:
19042026
Items per page

Supplemental Content

Support Center